Nikita Bondarev

Nikita Bondarev

Auto-generated profile, based on publicly available information

Nikita Bondarev

Insilico Medicine AI Limited, Level 6, Unit 08, Block A, IRENA HQ Building, Masdar City, UAE

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 March 2026 in Scientific Data
Verified
Journal Article
Open access
PDF file
BZBogdan Zagribelnyy
Bogdan Zagribelnyy
VAVladimir Aladinskiy
Vladimir Aladinskiy
NBNikita Bondarev
Nikita Bondarev
IIIvan Ilin
Ivan Ilin
MMMaxim Malkov
Maxim Malkov
AZAlex Zhavoronkov
Alex Zhavoronkov
The exploration and mapping of chemical space remain a central challenge in modern drug discovery. Traditional compound libraries and databases cover only a minute fraction of this space, limiting the discovery of novel, bioactive, and patentable chemotypes. Here, we present a unique dataset containing approximately 110 M molecular structures of potential NLRP3 inhibitors enabled by the LEGION ( Latent Enumeration, Generation, Integration, Optimization, and Navigation ) workflow, which integrates generative AI, AI-guided screening within the Chemistry42 platform and auxiliary cheminformatics tools to enable large-scale exploration of chemical space around specific drug targets. Using the structural data of NLRP3 co-crystals, a clinically relevant target, LEGION combined ligand- and structure-based design strategies, in-house algorithms for 3D pharmacophore-aware scaffold extraction, and distinct library enumeration methods to identify over 34,000 unique scaffolds, which can be multiplied into a dataset of 123B molecular structures within the provided code. The resulting dataset of unprecedented size proved effective for scaffold hopping, chemical space navigation, and supporting intellectual property applications by generating structurally diverse and synthetically accessible structures.

7 August 2025 in ChemRxiv
Verified
Preprint
Open access
PDF file
BZBogdan Zagribelnyy
Bogdan Zagribelnyy
VAVladimir Aladinskiy
Vladimir Aladinskiy
NBNikita Bondarev
Nikita Bondarev
IIIvan Ilin
Ivan Ilin
MMMaxim Malkov
Maxim Malkov
AZAlex Zhavoronkov
Alex Zhavoronkov
The exploration and mapping of chemical space – the vast, multidimensional set of all small organic molecules – remains a central challenge in modern drug discovery. Traditional compound libraries and databases cover only a minute fraction of this space, limiting the discovery of novel, bioactive, and patentable chemotypes. Here, we present LEGION, an advanced workflow that integrates generative AI, AI-guided screening, and state-of-the-art cheminformatics tools within the Chemistry42 platform to enable comprehensive, large-scale exploration of chemical space around specific drug targets. Using NLRP3, a clinically relevant but structurally complex inflammasome protein, as a case study, LEGION combined ligand- and structure-based design strategies, in-house algorithms for 3D pharmacophore-aware scaffold extraction, and distinct library enumeration methods to identify over 34,000 unique scaffolds and generate approximately 110 million molecular structures. Iterative stages of 2D and 3D filtering, including machine learning and structure-based pharmacophore scoring, ensured the binding relevance and structural feasibility of the enumerated compounds. The resulting workflow proved effective for scaffold hopping, navigating unexplored regions of chemical space, and supporting intellectual property applications through the generation of structurally diverse and synthetically tractable structures. This work demonstrates, for the first time, an AI-enabled framework capable of both massive virtual screening and de novo compound generation, specifically tailored for extensive chemical space coverage around a biological target. LEGION establishes a new paradigm for the intelligent, scalable, and practical exploration of chemical space in drug discovery.